Duke Law School shield Duke Law & Technology Review logo
TOPICS
eCommerce
eDiscovery
CyberCrime
International
Media & Comm.
Patents & Tech.
Health & Biotech.
Copyrights & TM.
 
DLTR Home
About DLTR
Contact DLTR
Submissions
Staff
Duke Law
This page has moved. You are being automatically redirected to the new location. If you are not redirected within a few seconds, please find the new page here.
Health & Biotechnology:
RECENT ARTICLES:
JUVENILE JUSTICE, SULLIVAN, AND GRAHAM: HOW THE SUPREME COURT’S DECISION WILL CHANGE THE NEUROSCIENCE DEBATE
  2010 Duke L. & Tech. Rev. 006
Health & Biotechnology
05/18/2010
Over the past twenty years, neuroscientists have discovered that brain maturation continues through an individual’s mid-twenties. The United States Supreme Court cited this research to support its abolition of the juvenile death penalty in Roper v. Simmons. Now the Court is faced with two cases that challenge the constitutionality of sentencing juveniles to life imprisonment without parole. Many believe these studies indicate that juveniles are both less culpable for their actions and more likely to reform; therefore, life in prison for juveniles is disproportionate, cruel, and unusual. However, others caution against the use of these studies in deciding issues of juvenile justice. This iBrief summarizes the cases currently before the Court, presents the arguments for and against the use of neuroscience in the juvenile justice debate, and analyzes the impact these cases will have on the future of neuroscience’s role in juvenile justice.


Archived Articles >>>

Title:

Date Posted
THE FUTURE OF GENERIC BIOLOGICS: SHOULD THE UNITED STATES “FOLLOW-ON” THE EUROPEAN PATHWAY? 11/06/2008
MCKITHEN V. BROWN: DUE PROCESS AND POST-CONVICTION DNA TESTING 09/30/2008
REGULATING NANOTECHNOLOGY:A PRIVATE-PUBLIC INSURANCE SOLUTION 02/13/2008
ENCOURAGING CORPORATE INNOVATION FOR OUR HOMELAND DURING THE BEST OF TIMES FOR THE WORST OF TIMES: EXTENDING SAFETY ACT PROTECTIONS TO NATURAL DISASTERS 11/2/2006
WHY TECHNOLOGY PROVIDES COMPELLING REASONS TO APPLY A DAUBERT ANALYSIS TO THE LEGAL STANDARD OF CARE IN MEDICAL MALPRACTICE CASES 11/2/2006
WHAT, IF ANY, ARE THE ETHICAL OBLIGATIONS OF THE U.S. PATENT OFFICE?: A CLOSER LOOK AT THE BIOLOGICAL SAMPLING OFINDIGENOUS GROUPS5/17/2006
ATTACK OF THE CLONES: LEGISLATIVE APPROACHES TO HUMAN CLONING IN THE UNITED STATES12/7/2005
WHEN THE PUBLIC DOES NOT HAVE A RIGHT TO KNOW: HOW THE CALIFORNIA PUBLIC RECORDS ACT IS DETERRING BIOSCIENCE RESEARCH AND DEVELOPMENT10/18/2005
TAKING BIOLOGICS FOR GRANTED? TAKINGS, TRADE SECRETS, AND OFF-PATENT BIOLOGICAL PRODUCTS3/1/2005
DISCLOSURE OF CLINICAL TRIAL DATA: WHY EXEMPTION 4 OF THE FREEDOM OF INFORMATION ACT SHOULD BE RESTORED2/17/2005
REGULATING INNOVATIVE MEDICINE: FITTING SQUARE PEGS IN ROUND HOLES1/13/2005
THE MEDICARE PRESCRIPTION DRUG, IMPROVEMENT, & MODERNIZATION ACT OF 2003: ARE WE PLAYING THE LOTTERY WITH HEALTHCARE REFORM?10/1/2004
ARE BIOTECH CROPS AND CONVENTIONAL CROPS LIKE PRODUCTS? AN ANALYSIS UNDER GATT10/29/2003
HATCH-WAXMAN REFORM AND ACCELERATED MARKET ENTRY OF GENERIC DRUGS: IS FASTER NECESSARILY BETTER?8/13/2003
REVIVING INFORMED CONSENT: USING RISK PERCEPTION IN CLINICAL TRIALS6/9/2003
THE CASE FOR NATIONAL DNA IDENTIFICATION CARDS 1/31/2003
DEFINING A NEW ETHICAL STANDARD FOR HUMAN IN VITRO EMBRYOS IN THE CONTEXT OF STEM CELL RESEARCH12/10/2002
REGULATING FUNCTIONAL FOODS: PRE- AND POST-MARKET STRATEGY11/25/2002
GENETIC TESTING IN THE WORKPLACE: THE EMPLOYER'S COIN TOSS9/5/2002
CUSTOMIZING CONCEPTION: A SURVEY OF PREIMPLANTATION GENETIC DIAGNOSIS AND THE RESULTING SOCIAL, ETHICAL, AND LEGAL DILEMMAS7/23/2002
APPROPRIATE AIMS: SETTING BOUNDARIES FOR REPROGENETIC TECHNOLOGY7/17/2002
EGREGIOUS ERROR OR ADMIRABLE ADVANCE: THE MEMORANDUM OF UNDERSTANDING THAT ENABLES FED ERALLY FUNDED BASIC HUMAN EMBRYONIC STEM CELL RESEARCH10/16/2001
A RECONSIDERATION OF THE PHYSICIANS' IMMUNITY STATUTE8/6/2001
THE CLONE WARS: THE GROWING DEBATE OVER FEDERAL CLONING LEGISLATION6/20/2001
WHERE THE WILD WIND BLOWS: GENETICALLY ALTERED SEED AND NEIGHBORING FARMERS5/3/2001
THE FATE OF GENE PATENTS UNDER THE NEW UTILITY GUIDELINES2/28/2001
Search:
Related Sites: